Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.5% in the afternoon session after the U.S. government opened an investigation into the national security implications of ...
Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters, backed by its impressive lineup of new products. The flourishing diabetes market provides a favorable opportunity for ...
StockStory.org on MSN
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and ...
The prognosticator behind that piece of bad news was Citigroup's Joanne Wuensch, who issued one of her bank's 90-day catalyst watches on Tandem stock before the market open. Wuensch wrote in her ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...
Tandem Diabetes Care (NASDAQ: TNDM) had some encouraging news to report on the regulatory front Thursday, and after it hit the headlines investors piled into the stock. At the end of the day the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback